Chat with AI
Clinical Laboratory Hematology 3rd Edition by Shirlyn McKenzie, Lynne Williams
Edition 3ISBN: 978-0133076011Clinical Laboratory Hematology 3rd Edition by Shirlyn McKenzie, Lynne Williams
Edition 3ISBN: 978-0133076011 Exercise 31
Promising new treatment for low risk MDS includes: (Objective 3)
A) AML-like chemotherapy
B) drugs that reverse epigenetic changes in the dysplastic stem cell
C) hematopoietic growth factors
D) bone marrow transplant
A) AML-like chemotherapy
B) drugs that reverse epigenetic changes in the dysplastic stem cell
C) hematopoietic growth factors
D) bone marrow transplant
Explanation
Verified
Verified
Hence, the options B, C and D are incorr...
Clinical Laboratory Hematology 3rd Edition by Shirlyn McKenzie, Lynne Williams
Why don’t you like this exercise?
Other Minimum 8 character and maximum 255 character
Character 255
